abstract |
The present specification relates to an anti-inflammatory composition containing a novel compound separated from post-fermented tea, an isomer thereof, a pharmaceutically acceptable salt thereof, a hydrate thereof, or a solvate thereof, and an anti-inflammatory related field. Can be widely used in. [Selection diagram] Figure 1 |